The 3 T’s: Positioning Ireland for FDI
What makes Ireland attractive for FDI? As the former general manager of Genzyme’s Waterford site, Pat O’Sullivan explains that a longstanding 12.5% corporate tax rate (that isn’t going anywhere)…
Address: Novo Nordisk Ireland, 2nd Floor, 2 Hume St. Dublin 2,Ireland
Tel: 1850 665665
Web: http://www.novonordisk.ie/documents/home_page/document/index.asp
General information:
Irish office: 3/4 Upper Pembroke Street, Dublin 2
Global headquarters: Bagsværd, Denmark
Irish workforce: 24 employees
Global workforce: More than 31,300 employees
International production facilities in seven countries
Product areas
Diabetes care
Hormone replacement therapy (HRT)
Haemostasis management
Growth hormone therapy.
Clinical research:
Before any medicine is available for doctors to prescribe, it must be granted a license by the government. Therefore, all medicines have to be tested in appropriate patients to ensure that they reach the standards of safety and efficacy required by governmental agencies around the world. This is achieved by conducting clinical trials in which patients freely volunteer to try new medicines so that relevant data can be obtained. All clinical trials must conform to globally accepted scientific and ethical standards before they can proceed.
Novo Nordisk is committed to ensuring that all its products meet the highest quality standards and are rigorously tested by performing clinical trials in collaboration with doctors and nurses around the world, including sites in Ireland.
Novo Nordisk way:
In 1923, our Danish founders began a journey to change diabetes.
Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes.
Our ambition is to strengthen our leadership in diabetes. Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world. We aspire to change possibilities in haemophilia and other serious chronic conditions where we can make a difference. Growing our business and delivering competitive financial results is what allows us to help patients live better lives, offer an attractive return to our shareholders and contribute to our communities.
We never compromise on quality and business ethics
Our business philosophy is one of balancing financial, social and environmental considerations – we call it ‘The Triple Bottom Line’
We are open and honest, ambitious and accountable, and treat everyone with respect
We offer opportunities for our people to realise their potential.
Every day, we must make difficult choices, always keeping in mind, what is best for patients, our employees and our shareholders in the long run.
It’s the Novo Nordisk Way.
Haemophilia and Eating Disorders.
Diabetes Care.
Hormone Replacement Therapy.
What makes Ireland attractive for FDI? As the former general manager of Genzyme’s Waterford site, Pat O’Sullivan explains that a longstanding 12.5% corporate tax rate (that isn’t going anywhere)…
Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs. Nearby, Pfizer was manufacturing citric acid for…
It is widely acknowledged that pharmaceutical manufacturing operations have entered into a period of significant cost reduction. Service providers like Dalkia—a French energy services company that has built its Irish…
“The government’s vision has always been for indigenous companies to develop from the expertise brought in by FDI—and we are seeing that happening now.” Joe Costello, Minister for Trade &…
“The elements that have made Ireland attractive for decades are still here. The big difference since 2007, however, is the cost base. If you are building a pharma plant…
Kells Stainless, founded in 1988, is celebrating 25 years this year. Looking back, what have been the company’s principal achievements over these decades? Originally, Kells Stainless was set up to…
Mr. Murphy, you first joined PM Group 24 years ago. How has the company, and the market, changed? My background, prior to joining PM Group, was in the pharmaceutical industry—I…
Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? Genzyme Waterford was set up in 2001, to support the manufacture of drug products for…
Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? Genzyme Waterford was set up in 2001, to support the manufacture of drug products for…
Fergal Murphy, Chairman of the Association of Pharmaceutical Manufacturers in Ireland, discusses with pharamaboardroom.com the difficulties in such a small market and how the industry is adapting to the needs…
Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some time as a post-doctoral researcher…
Can you please introduce yourself, and Ernst & Young’s life science practice in Ireland, to our readers? I am the managing partner of Ernst & Young (EY) in Ireland, responsible…
See our Cookie Privacy Policy Here
